Simple vs Complex Cysts (Bosniak detail)
- A simple renal cyst is a bag of water with a hair-thin wall (≤2 mm) and nothing growing inside: homogeneous, −10 to +20 HU on CT, no enhancement. It needs zero follow-up.
- A complex cyst has features that make you nervous: thickened or irregular walls, septa, or a nodule. Calcification, on its own, no longer counts against it.
- Bosniak version 2019 grades that complexity in millimetres: thin ≤2 mm (I or II), minimally thickened 3 mm or ≥4 thin septa (IIF), thick ≥4 mm or irregular (III), nodule (IV).
- Enhancement is the feature that does all the work. Enhancing tissue means living, blood-supplied cells, and that is what we fear in a cyst wall.
- Two shortcuts close cases without a dedicated study: a homogeneous mass ≥70 HU on unenhanced CT is a hyperdense benign cyst, and a homogeneous 21–30 HU mass on a portal venous scan is Bosniak II.
Renal cysts are the freckles of the abdomen. Scan enough kidneys and you will find them everywhere, usually meaning nothing. The whole job is telling the harmless freckle apart from the rare one that is actually trouble, and radiology has a tidy rulebook for exactly that, named after the radiologist who built it. This page is about the two ends of that rulebook: the simple cyst you can sign off in your sleep, and the complex cyst that needs measuring. The full ladder, with every millimetre, lives on the Bosniak v2019 classification page.
The simple cyst: a water balloon, and that's the entire story
Picture a perfectly clean water balloon tucked into the kidney. Thin rubber wall, clear water inside, no lumps, no strings, no grit. That is a simple cyst, and its checklist is so strict it is almost boring:
- Round or oval, sharply marginated against the kidney.
- Wall so thin you can barely see it, ≤2 mm, a pencil line.
- Contents that measure like water. On CT that is a homogeneous −10 to +20 Hounsfield units, dark, uniform, no internal texture.
- No enhancement. Squirt contrast in and the cyst stays exactly as dark as before. (The hair-thin wall itself may enhance faintly; that is allowed.)
Tick every box and you are done. No follow-up, no biopsy, no worried phone call.
A truly simple cyst is one of the few findings in radiology where the correct next step is nothing. Resist the urge to recommend a follow-up scan just to feel thorough. Over-imaging a water balloon helps no one.
When the balloon gets complicated
Now imagine that clean balloon starts misbehaving. The wall thickens. Strings stretch across the inside. A little nodule buds off a wall. Each of these is a reason to look harder, because cancer, specifically renal cell carcinoma, can present as a cyst rather than a solid lump. That is the trap: not every kidney cancer is an obvious ball of tissue. Some hide as a cyst that is almost simple.
Here is the concept worth tattooing on your forearm. Enhancement means a structure has a working blood supply. Inject contrast and anything with living, perfused cells gets brighter. Plain fluid has no blood supply, so it stays stubbornly dark. So when a septum or nodule inside a cyst enhances, you are not looking at a fold of debris. You are looking at tissue with plumbing, and tissue with plumbing is the calling card of a tumor.
The 2019 revision made one other thing simpler: calcification stopped mattering. Any type of calcification is allowed in a benign class II cyst. Calcium is a scar of old bleeding or infection, not evidence of growth. What raises the class is enhancing tissue that is thick, numerous, irregular, or nodular.
Findings by modality
CT
CT is the reference modality, because the Bosniak definitions are written in Hounsfield units and millimetres. A renal-mass-protocol CT has an unenhanced series and at least one post-contrast series (usually the nephrographic phase, when the parenchyma is uniformly bright and a wall or septum is easiest to judge against it).
- Simple cyst: homogeneous −10 to +20 HU on the unenhanced series, no change after contrast, wall ≤2 mm.
- Hyperdense cyst: homogeneous ≥70 HU on the unenhanced series (blood products or protein); no enhancement on the post-contrast pair. Bosniak II.
- Septa and walls: measure the thickest enhancing one at its widest point, perpendicular to its long axis, on thin slices. Count the septa. Look for a convex protrusion and decide whether its margins are obtuse (a hill) or acute (a mushroom).
- Heterogeneity: any mixed attenuation on the unenhanced series takes the mass out of every shortcut. RCC is almost always heterogeneous unenhanced; a homogeneous mass under 20 HU is rarely RCC.
Ultrasound
The simple cyst is even prettier here: pitch-black inside (anechoic), a thin smooth back wall, and bright posterior acoustic enhancement behind it because sound sails through fluid unimpeded. Ultrasound shows septa and wall thickness beautifully and often counts septa better than CT, but it cannot measure contrast uptake, so it cannot assign a class above what its morphology shows. A cyst that is anechoic with a thin wall and no septa on ultrasound is simple; anything with septa, a thick wall, or internal echoes goes to CT or MRI.
MRI
MRI is the tie-breaker. Simple fluid is uniformly dark on T1 and bright on T2; blood products or protein make a cyst bright on T1. Wall and septal enhancement is judged on subtracted post-contrast images, which removes the confusion of an already-bright hemorrhagic cyst. The ACR white paper prefers MRI for masses <1.5 cm and for detecting enhancement in suspected hypovascular masses. The v2019 system carries the same millimetre definitions over to MRI; I am deliberately not quoting its MRI-specific signal-based shortcuts here.
The numbers
| What | Threshold / value | Why it matters |
|---|---|---|
| Simple cyst on CT | Homogeneous −10 to +20 HU, no enhancement | Bosniak I; no further evaluation |
| Simple fluid (Bosniak wording) | −9 to 20 HU | The v2019 class I and class II definition of simple fluid |
| Thin wall or septum | ≤2 mm | Class I (no septa) or class II (1–3 septa) |
| Hyperdense cyst | Homogeneous ≥70 HU on unenhanced CT | Class II; unenhanced rule only |
| Non-enhancing homogeneous mass | >20 HU with no enhancement on a pre/post pair | Class II |
| Portal venous shortcut | Homogeneous 21–30 HU on the portal venous phase | Class II |
| Minimally thickened wall or septum | 3 mm, smooth, enhancing | Class IIF; follow-up imaging |
| Many septa | ≥4 smooth thin (≤2 mm) enhancing septa | Class IIF |
| Thick wall or septum | ≥4 mm, enhancing | Class III; urologic referral |
| Irregular wall or septum | ≤3 mm obtusely margined convex protrusions, enhancing | Class III |
| Nodule | ≥4 mm convex protrusion with obtuse margins, or any size with acute margins, enhancing | Class IV |
| Indeterminate homogeneous mass | >20 and <70 HU unenhanced, or >20 HU contrast-only | Needs pre- and post-contrast characterization |
| MRI preferred | Masses <1.5 cm; suspected hypovascular masses | Subtle enhancement is easier to prove |
| Stable cyst | No feature change and growth ≤3 mm per year for at least 5 years | No further workup |
How good is the test
The honest answer is that there is no robust pooled sensitivity or specificity for CT, ultrasound, or MRI at separating benign from malignant cystic renal masses, so I will not invent one. What I can give you is the class-level risk as summarized by the v2019 authors: roughly half of Bosniak III masses and roughly 90% of Bosniak IV masses are malignant, while classes I and II are benign and need no follow-up. That is the closest thing to a performance figure in this topic, and it is the number the urologist is working from.
The Bosniak ladder, abbreviated
Bosniak classification, version 2019, abbreviated. Full table with every subtype on the classification page.
| Class | Defining features | Action |
|---|---|---|
| I | Thin (≤2 mm) smooth wall; homogeneous simple fluid (−9 to 20 HU); no septa | Benign; no follow-up |
| II | Thin wall with few (1–3) thin (≤2 mm) septa, any calcification; or homogeneous ≥70 HU unenhanced; or homogeneous non-enhancing >20 HU; or homogeneous 21–30 HU portal venous; or homogeneous −9 to 20 HU unenhanced; or homogeneous low-attenuation TSTC | Benign; no follow-up |
| IIF | Smooth minimally thickened (3 mm) enhancing wall or septa; or ≥4 smooth thin enhancing septa | Follow-up imaging |
| III | Enhancing thick (≥4 mm) or irregular (≤3 mm obtuse protrusions) wall or septa | Indeterminate, roughly half malignant; urologic referral |
| IV | Enhancing nodule (≥4 mm obtuse, or any size acute margins) | Roughly 90% malignant; treatment for appropriate candidates |
The "F" in IIF stands for follow-up, not "fine." These cysts have features just shy of worrisome, so we watch them over time rather than ignoring or removing them. It is the radiology equivalent of "let's keep an eye on that."
Mimics and how to separate them
| Mimic | Looks similar because | Tell them apart by |
|---|---|---|
| Hyperdense (hemorrhagic or proteinaceous) cyst | Bright and solid-looking on a single phase | Homogeneous ≥70 HU on unenhanced CT; no enhancement on a pre/post pair; on MRI, bright on T1 with no subtraction enhancement |
| Cystic renal cell carcinoma | Fluid core, thin wall in places | Enhancing thick (≥4 mm) or irregular walls or septa, or an enhancing nodule; heterogeneous unenhanced |
| Necrotic solid RCC | Central low attenuation | Mostly enhancing solid tissue with a fluid center rather than a fluid mass with a thin lining |
| Angiomyolipoma with a low-attenuation component | Dark region on soft-tissue windows | Region of interest measures fat, < −10 HU, not water |
| Pseudoenhancement of a small cyst | Apparent small rise in HU after contrast in a cyst buried in bright cortex | The setting (small, intraparenchymal); there is no accepted HU cutoff, so arbitrate with MRI or ultrasound |
| Papillary RCC on a single post-contrast phase | Enhances weakly and can read as a slightly dense cyst | Homogeneous >20 HU on contrast-only CT (outside the 21–30 HU portal venous exception) needs a pre/post pair; MRI preferred for hypovascular masses |
Grading a cyst you can't actually grade. Bosniak assumes a study in which enhancement can be judged. On a non-contrast scan you cannot assess enhancement, the one feature that matters most, so you cannot assign class IIF, III, or IV. You can still close the benign ones through the attenuation shortcuts. Otherwise, describe and recommend the study that can answer the question.
Reporting
For a simple cyst, one line: "Simple cyst, left kidney, 2 cm; no further evaluation needed." Say the second half out loud; it stops a follow-up scan that would only find the same balloon.
For a complex cyst, the referrer needs:
- Location and size in three planes, and whether it is exophytic or central.
- The phase you measured on and the attenuation ("homogeneous, 74 HU on the unenhanced series").
- The feature that set the class, with its measurement: "smooth enhancing wall, 3 mm" or "enhancing septum, 5 mm" or "4 mm enhancing nodule with obtuse margins."
- The class with its version: "Bosniak IIF (v2019)."
- The action the class implies: no follow-up, follow-up imaging, urologic referral, or treatment discussion.
- Whether the study could actually grade it, and if not, what would.
If you want the bigger picture of how any kidney lesion gets worked up, solid or cystic, start with the approach to the renal mass, and for the step-by-step on cystic ones specifically, the approach to the cystic renal mass. But for cysts the takeaway compresses into one line: describe the wall and septa in millimetres, then ask the only question that really matters. Does anything in here enhance? The answer is the difference between a freckle and a phone call.
References
- Silverman SG, Pedrosa I, Ellis JH, et al. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment. Radiology 2019;292(2):475–488. Used for: the ≤2 mm thin, 3 mm minimally thickened, and ≥4 mm thick wall and septal definitions; the 1–3 few and ≥4 many septa counts; the ≤3 mm irregular protrusion and the ≥4 mm obtuse-margined or any-size acute-margined nodule definitions; the −9 to 20 HU simple fluid, ≥70 HU unenhanced, >20 HU non-enhancing, 21–30 HU portal venous, and too-small-to-characterize class II subtypes; the "roughly half" (III) and "roughly 90%" (IV) malignancy summaries; the per-class actions; and the "calcification of any type allowed" rule, in "Findings by modality," "The numbers," "How good is the test," "The Bosniak ladder, abbreviated," "Mimics," and "Reporting."
- Herts BR, Silverman SG, Hindman NM, et al. Management of the Incidental Renal Mass on CT: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol 2018;15(2):264–273. Used for: the −10 to +20 HU simple-cyst band; the ≥70 HU unenhanced hyperdense-cyst rule and its restriction to unenhanced CT; the >20 and <70 HU (unenhanced) and >20 HU (contrast-only) indeterminate bands; the < −10 HU fat threshold; the <1.5 cm MRI preference and the hypovascular-mass MRI preference; the ≤3 mm per year for at least 5 years stability rule; and the statement that RCC is almost always heterogeneous unenhanced while a homogeneous mass under 20 HU is rarely RCC, in "Findings by modality," "The numbers," "Mimics," and "Reporting."
Sign in to take the quiz and track your progress